FSD Pharma

FSD Pharma Takes Steps to Mitigate the Impact of COVID-19 on its Cannabis Production Facility in Cobourg, Ontario

Source: FSD Pharma Published on 2020-03-23

InvestmentPitch Media Video Discusses FSD Pharma's Initiation of Phase 1 In-Human Safety & Tolerability Study of Dosing Ultra Micro-PEA for Targeting CB2 Receptors at Alfred Hospital in Australia - Video Available on Investmentpitch.com

Source: FSD Pharma Published on 2020-03-10

FSD Pharma Begins Phase 1 In-human Safety and Tolerability Study of Ultra Micro-Palmitolylethanolamide (PEA)

Source: FSD Pharma Published on 2020-03-09

FSD Pharma Inc., Worldwide License of Natural Fatty Acid, CEO Clip Video

Source: FSD Pharma Published on 2020-03-06

FSD Pharma to Ring the Opening Bell of the Canadian Securities Exchange On Friday, March 6, 2020

Source: FSD Pharma Published on 2020-03-04

FSD Pharma to Ring the Opening Bell of the Canadian Securities Exchange on Friday, March 6, 2020

Source: FSD Pharma Published on 2020-03-04

InvestmentPitch Media Video Discusses FSD Pharma's Sale of its 12% Interest in Cannara Biotech Generating 670% Return and $7.7 million in Proceeds - Video Available on Investmentpitch.com

Source: FSD Pharma Published on 2020-02-24

FSD Pharma Generates $7.7 Million in Proceeds and 670% Return on Investment through Sale of Interest in Cannara Biotech

Source: FSD Pharma Published on 2020-02-20

FSD Pharma CEO, Dr. Raza Bokhari, Discusses 2020 Goals with The Stock Day Podcast

Source: FSD Pharma Published on 2020-02-11

FSD Pharma Chairman & CEO to Present at 22nd Annual BIO CEO & Investor Conference in NYC

Source: FSD Pharma Published on 2020-02-05

FSD Pharma and Solarvest Enhance Commitment to CBD Research Project

Source: FSD Pharma Published on 2020-02-04

FSD Pharma and Solarvest Enhance Commitment to CBD Research Project

Source: FSD Pharma Published on 2020-02-04

Seasoned Healthcare Executive and Academic Luminary Larry Kaiser, MD, Joins FSD Pharma Board of Directors

Source: FSD Pharma Published on 2020-01-22

Seasoned Healthcare Executive and Academic Luminary Larry Kaiser, MD, Joins FSD Pharma Board of Directors

Source: FSD Pharma Published on 2020-01-22

FSD Pharma to Ring Nasdaq Opening Bell on Wednesday, January 22, 2020

Source: FSD Pharma Published on 2020-01-17

InvestmentPitch Media Video Discusses FSD Pharma's New Listing on the Nasdaq Capital Market and Upcoming Biotech and Healthcare Conferences - Video Available on Investmentpitch.com

Source: FSD Pharma Published on 2020-01-10

FSD Pharma to Commence Trading on Nasdaq Capital Market Under Symbol ‘HUGE’

Source: FSD Pharma Published on 2020-01-09

FSD Pharma to Commence Trading on Nasdaq Capital Market Under Symbol 'HUGE'

Source: FSD Pharma Published on 2020-01-09

FSD Pharma to Begin Trading on the NASDAQ Capital Market Under Symbol ‘HUGE’ on January 9, 2020

Source: FSD Pharma Published on 2020-01-06

FSD Pharma to Begin Trading on the NASDAQ Capital Market Under Symbol 'HUGE' on January 9, 2020

Source: FSD Pharma Published on 2020-01-06

FSD Pharma Strengthens Management Team

Source: FSD Pharma Published on 2020-01-02

InvestmentPitch Media Video Discusses FSD Pharma's Approval of Listing Application for Nasdaq Capital Market with trading Anticipated to Begin Shortly - Video Available on Investmentpitch.com

Source: FSD Pharma Published on 2019-12-17

IIROC Trade Resumption - HUGE

Source: FSD Pharma Published on 2019-12-16

FSD Pharma Receives Approval to List Its Shares on Nasdaq

Source: FSD Pharma Published on 2019-12-16

FSD Pharma Receives Approval to List its Shares on Nasdaq

Source: FSD Pharma Published on 2019-12-16

IIROC Trading Halt - HUGE

Source: FSD Pharma Published on 2019-12-13

FSD Pharma to Present at Investor Summit on December 17

Source: FSD Pharma Published on 2019-12-13

HUGE.CN: FSD Pharma to Initiate a Phase 1 clinical trial of PP-101 micro-PEA during 1Q 2020

Source: FSD Pharma Published on 2019-12-13

FSD Pharma to Present at 12th Annual LD Micro Main Event Investor Conference on December 11

Source: FSD Pharma Published on 2019-12-05

FSD Pharma to Present at 12th Annual LD Micro Main Event Investor Conference on December 11

Source: FSD Pharma Published on 2019-12-05

FSD Pharma Reports Third Quarter 2019 Financial Results

Source: FSD Pharma Published on 2019-11-29

FSD Pharma Reports Third Quarter 2019 Financial Results

Source: FSD Pharma Published on 2019-11-29

Canadian Securities Exchange Attracts First Israeli Company Listings

Source: FSD Pharma Published on 2019-11-05

FSD Pharma Second Tranche of Private Placement Closes, Total of $4.59 Million Raised at $20.10 To Date, Extends Offering

Source: FSD Pharma Published on 2019-11-04

FSD Pharma, New Sales License is a Key Development, CEO Clip Video

Source: FSD Pharma Published on 2019-10-28

FSD Pharma Announces the Filing of an Amended Annual MD&A for 2018

Source: FSD Pharma Published on 2019-10-23

HUGE.CN: FSD Pharma Undergoes Share Consolidation in Management’s Effort to Uplist in the U.S.

Source: FSD Pharma Published on 2019-10-23

InvestmentPitch Media Feature Video Discusses FSD Pharma and a Recent Commentary by CEO Raza Bokhari, MD - Video is Available on Investmentpitch.com

Source: FSD Pharma Published on 2019-10-22

InvestmentPitch Media Video Discusses FSD Pharma's New OTCQB Symbol and Appointment of Former U.S. Congressman Stephen Buyer to its Board of Directors - Video Available on Investmentpitch.com

Source: FSD Pharma Published on 2019-10-18

FSD Pharma Announces Temporary Change in OTCQB Ticker Symbol to FSDDD

Source: FSD Pharma Published on 2019-10-17

FSD Pharma Appoints Former Member of U.S. Congress to its Board of Directors, Announces Share Consolidation

Source: FSD Pharma Published on 2019-10-11

FSD Pharma Closes First Tranche of Private Placement at $4.58 Million, Extends Offering

Source: FSD Pharma Published on 2019-10-01

InvestmentPitch Media Video Discusses FSD Pharma's LOI with World Class Extractions Creating JV to Build and Operate Cannabis Extraction/Processing Facility in Cobourg, Ontario - Video Available on Investmentpitch.com

Source: FSD Pharma Published on 2019-09-26

FSD Pharma Signs LOI to Establish Joint Venture with World-Class Extractions to Deploy Full Extraction Processing Center

Source: FSD Pharma Published on 2019-09-25

HUGE.CN: Zacks Initiates Coverage of FSD Pharma Inc.

Source: FSD Pharma Published on 2019-09-24

FSD Pharma Launches Online System for Medicinal Cannabis Orders

Source: FSD Pharma Published on 2019-08-30

FSD Pharma Announces Private Placement

Source: FSD Pharma Published on 2019-08-30

FSD Pharma Launches Online Ordering System for Medicinal Cannabis Fulfillment

Source: FSD Pharma Published on 2019-08-21

Aura Announces Pharmadrug Operational & Investor Relations Update

Source: FSD Pharma Published on 2019-08-13

FSD Pharma Appoints Larry Kaiser, MD, FACS, Dean, Lewis Katz School of Medicine at Temple University as Chairman of Its Scientific Advisory Board

Source: FSD Pharma Published on 2019-07-30

FSD.CN

Recent Headlines

Interview – John Arbuthnot CEO of Delta-9 Outstanding Quarterly Results and COVID-19 Business Impact

The Largest Pot Stock in the World Is Cutting Production Big Time

Why Alberta continues to lose money on legal cannabis